Abstract
Background Diarrhea is one of the leading causes of childhood morbidity and mortality in lower- and middle-income countries. In such settings, access to laboratory diagnostics are often limited, and decisions for use of antimicrobials often empiric. Clinical predictors are a potential non-laboratory method to more accurately assess diarrheal etiology, the knowledge of which could improve management of pediatric diarrhea.
Methods We used clinical and quantitative molecular etiologic data from the Global Enteric Multicenter Study (GEMS), a prospective, case-control study, to develop predictive models for the etiology of diarrhea. Using random forests, we screened the available variables and then assessed the performance of predictions from random forest regression models and logistic regression models using 5-fold cross-validation.
Results We identified 1049 cases where a virus was the only etiology, and developed predictive models against 2317 cases where the etiology was known but non-viral (bacterial, protozoal, or mixed). Variables predictive of a viral etiology included age, season, height-for-age z-score (HAZ), bloody diarrhea, and vomiting. Cross-validation suggests an AUC of 0.825 can be achieved with a parsimonious model of 5 variables, achieving a specificity of 0.85, a sensitivity of 0.59, a NPV of 0.82 and a PPV of 0.64.
Conclusion Predictors of the etiology of pediatric diarrhea can be used by providers in low-resources setting to inform clinical decision-making. The use of non-laboratory methods to diagnose viral causes of diarrhea could reduce inappropriate antibiotic prescription worldwide.
Author Summary Diarrhea is one of the leading causes of death in young children worldwide. In low-resource settings, diarrhea testing is not available or too expensive, and the decision to prescribe antibiotics is often made without testing. Using clinical information to predict which cases are caused by viruses, and thus wouldn’t need antibiotics, would help to improve appropriate use of antibiotics. We used data from a large study of childhood diarrhea, paired with advanced statistical methods including machine learning, to come up with the top clinical factors that could predict a viral cause of diarrhea. We compared 1049 cases where a virus was the only cause, with 2317 cases where the cause was known but not a virus. We found that age, season, nutritional status defined by height, blood diarrhea, and vomiting, were the clinical factors most predictive of whether the diarrhea was caused by a virus or not. We found that, using just those 5 factors, we were able to predict a viral cause with good accuracy. Our findings can be used by doctors to guide the appropriate use of antibiotics for diarrhea in children.
Competing Interest Statement
ATP has received royalties from Antimicrobial Therapy Inc. and consulting fees from Merck, Genentech and Sequirius, unrelated to the current work
Funding Statement
This work was supported by the National Institute of Health [R01 AI135114 to D.T.L., R01 AI125642 and R34 AI136783 to A.T.P.] at https://www.nih.gov/grants-funding, the NIH National Center for Advancing Translation Sciences [UL1TR002538 to B.H. and T.G.] at https://ncats.nih.gov, and The Bill and Melinda Gates Foundation [OPP1198876 to D.T.L.] at https://www.gatesfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Powered
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.